SCHEMBL8187635

SCHEMBL8187635

CCCC(=O)c1cnc2c(OCC[S+](C)[O-])cccc2c1Nc1ccccc1C

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 1/20 0.73
▸ ATP4B P51164 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8193199 0.96 ATP4A (0.72) ATP4AATP4B
SCHEMBL9394652 0.94 ATP4A (0.66) ATP4AATP4B
SCHEMBL8178451 0.94 ATP4A (0.64) ATP4AATP4B
SCHEMBL8194310 0.92 ATP4A (0.60) ATP4AATP4B
SCHEMBL8190801 0.91 ATP4A (0.68) ATP4AATP4B
SCHEMBL8177593 0.91 ATP4A (0.60) ATP4AATP4B
SCHEMBL8187735 0.91 — —
SCHEMBL8190470 0.91 — —
SCHEMBL8189000 0.90 ATP4A (0.59) ATP4AATP4B
SCHEMBL8188049 0.90 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0702672-B1 SUBSTITUTED QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION ASTRAZENECA AB (SE) 2000-09-06 — — EP claimed
US-5889021-A GASTROINTESTINAL DISORDERS; ANTISECRETORY AGENTS; ANTIINFLAMMATORY AGENTS ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US claimed
EP-0796249-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION Astra Aktiebolag (SE) 1997-09-24 — — EP claimed
US-5556863-A ANTIINFLAMMATORY AGENTS AND ANTISECRETORY AGENTS FOR GASTRIC JUICE ASTRA AKTIEBOLAG (SE) 1996-09-17 — — US claimed
WO-1996017830-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION ASTRA AKTIEBOLAG (SE) 1996-06-13 — — WO claimed
EP-0702672-A1 NEW ACTIVE COMPOUNDS AKTIEBOLAGET ASTRA (SE) 1996-03-27 — — EP claimed
WO-1994029274-A1 NEW ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (SE) 1994-12-22 — — WO claimed
EP-0702672-B1 SUBSTITUTED QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION ASTRAZENECA AB (SE) 2000-09-06 — — EP disclosed
US-5889021-A GASTROINTESTINAL DISORDERS; ANTISECRETORY AGENTS; ANTIINFLAMMATORY AGENTS ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US disclosed
CN-1169142-A Compounds for inhibiting gastric acid secretion ASTRA AB (SE) 1997-12-31 — — CN disclosed
EP-0796249-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION Astra Aktiebolag (SE) 1997-09-24 — — EP disclosed
EP-0796249-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION Astra Aktiebolag (SE) 1997-09-24 — — EP disclosed
US-5556863-A ANTIINFLAMMATORY AGENTS AND ANTISECRETORY AGENTS FOR GASTRIC JUICE ASTRA AKTIEBOLAG (SE) 1996-09-17 — — US disclosed
WO-1996017830-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION ASTRA AKTIEBOLAG (SE) 1996-06-13 — — WO disclosed
WO-1996017830-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION ASTRA AKTIEBOLAG (SE) 1996-06-13 — — WO disclosed
EP-0702672-A1 NEW ACTIVE COMPOUNDS AKTIEBOLAGET ASTRA (SE) 1996-03-27 — — EP disclosed
WO-1994029274-A1 NEW ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (SE) 1994-12-22 — — WO disclosed
Send feedback